| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |